BRIEF published on 04/04/2025 at 14:59, 1 year 7 months ago EUROPLASMA: Balance sheet of voting rights and shares as of March 31, 2025 Share Capital Voting Rights Outstanding Shares Europlasma Euronext Growth
PRESS RELEASE published on 04/04/2025 at 14:55, 1 year 7 months ago EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 mars 2025 EUROPLASMA déclare le nombre total de droits de vote et d'actions au 31 mars 2025, conformément à la réglementation financière Droits De Vote Capital Social Actions Europlasma Finance
PRESS RELEASE published on 04/04/2025 at 14:54, 1 year 7 months ago EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 mars 2025 EUROPLASMA communique le nombre total de droits de vote et d'actions au 31 mars 2025 conformément à la réglementation Capital Droits De Vote Actions Europlasma Circulation
BRIEF published on 03/31/2025 at 18:20, 1 year 7 months ago Europlasma procède au tirage du troisième Investor Call Financement Obligations Convertibles Europlasma Décarbonation Dilution Actionnaire
BRIEF published on 03/31/2025 at 18:20, 1 year 7 months ago Europlasma proceeds with the drawing of the third Investor Call Decarbonization Convertible Bonds Shareholder Dilution Funding Europlasma
PRESS RELEASE published on 03/31/2025 at 18:15, 1 year 7 months ago EUROPLASMA: EXERCICE DU TROISIÈME INVESTOR CALL Europlasma annonce le tirage de la huitième tranche d'obligations convertibles pour financer sa croissance. Détails sur les activités soutenues et les risques associés Croissance Obligations Convertibles Europlasma Risques Tirage
BRIEF published on 03/19/2025 at 19:05, 1 year 7 months ago Europlasma lance la septième tranche d'obligations convertibles Obligations Convertibles Europlasma Dilution Croissance Stratégique Investissement Industriel
BRIEF published on 03/19/2025 at 19:05, 1 year 7 months ago Europlasma launches the seventh tranche of convertible bonds Convertible Bonds Europlasma Strategic Growth Dilution Industrial Investment
PRESS RELEASE published on 03/19/2025 at 19:00, 1 year 7 months ago EUROPLASMA: EXERCICE DU DEUXIÈME INVESTOR CALL Europlasma annonce le tirage de la septième tranche d'obligations convertibles en actions pour financer la croissance. Investment, obligations, croissance industrielle Croissance Investissement Europlasma Industrie Obligations
BRIEF published on 03/19/2025 at 18:35, 1 year 7 months ago Europlasma : Exercice du Deuxième Investor Call Croissance Financement Obligations Convertibles Europlasma Dilution
Published on 11/06/2026 at 22:15, 2 days 12 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 21 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 22 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 22 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 10:05, 29 minutes ago Reactive Technologies Appoints Former Hitachi Energy CEO Claudio Facchin as Board Chairman
Published on 11/09/2026 at 10:00, 35 minutes ago Deutsche Beteiligungs AG: Green Datahub data centres successfully sold
Published on 11/09/2026 at 09:30, 1 hour 5 minutes ago Shelly Group: Invitation to Earnings Webcast/Call on 11 November 2026 on Unaudited 9M 2026 Results
Published on 11/09/2026 at 09:00, 1 hour 34 minutes ago Cantourage further develops Telecan and strengthens digital access to medical care
Published on 11/09/2026 at 07:00, 3 hours 35 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 3 hours 35 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 3 hours 35 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 3 hours 35 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 15 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
